PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +7.0% · netto nieuwe posities -5.3% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +3 | 113.08M | $1.17B | +10 | −8 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | n/a | n/a |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | n/a |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | n/a | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | n/a | −1 |
| Q2 2024 | 15 | n/a | 10.85M | $278.70M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 16.92M | +16.3% | $376.82M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 2 | The Vanguard Group ✦ (passief) | 13.88M | -1.0% | $309.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passief) | 13.48M | +2.6% | $300.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 4 | State Street Global Advisors ✦ (passief) | 6.90M | -6.0% | $153.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 3.17M | +279.9% | $70.55M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 2.72M | +10.6% | $60.48M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 2.05M | +2.5% | $45.67M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 8 | Morgan Stanley ✦ | 1.48M | n/a | $32.97M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 9 | GAMCO Investors ✦ | 855.50K | -4.9% | $19.05M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 576.75K | n/a | $12.84M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | JPMorgan Chase ✦ | 523.49K | n/a | $11.66M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 12 | Arrowstreet Capital ✦ | 517.77K | +60.2% | $11.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 259.00K | -37.6% | $5.77M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 182.54K | -54.9% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | D. E. Shaw & Co. ✦ | 67.03K | Nieuw | $1.49M | 0.0% | New | 1 | SEC ↗ ×2 |
| 16 | AQR Capital Management ✦ | 25.46K | +17.4% | $553,668 | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 17 | Gotham Asset Management ✦ | 14.55K | -88.5% | $324,051 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 9.14K | +19.5% | $203,525 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 2.06K | -99.4% | $45,813 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| D. E. Shaw & Co. | $1.49M | 0.0% |
Verlaten
| Norges Bank | $36.75M | was 0.0% |
| Two Sigma Investments | $766,276 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 326 houders, 151.12M aandelen, $1.41B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.